Related references
Note: Only part of the references are listed.Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma
Robert Pola et al.
ACTA BIOMATERIALIA (2021)
Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling
Ladislav Sivak et al.
JOURNAL OF CONTROLLED RELEASE (2021)
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy
Marina R. Tavares et al.
PHARMACEUTICS (2021)
HPMA-Based Polymer Conjugates for Repurposed Drug Mebendazole and Other Imidazole-Based Therapeutics
Martin Studenovsky et al.
POLYMERS (2021)
Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment
Linda K. Rushworth et al.
BRITISH JOURNAL OF CANCER (2020)
Autophagy Is a Potential Target for Enhancing the Anti-Angiogenic Effect of Mebendazole in Endothelial Cells
So Jung Sung et al.
BIOMOLECULES & THERAPEUTICS (2019)
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
Kristin Blom et al.
BMC RESEARCH NOTES (2019)
Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
Nilambra Dogra et al.
SCIENTIFIC REPORTS (2018)
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation
Kristin Blom et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2017)
Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis
Laine Celestino Pinto et al.
TOXICOLOGY IN VITRO (2017)
The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma
Cynthia M. Simbulan-Rosenthal et al.
ONCOTARGET (2017)
Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC)
Fugui Zhang et al.
ONCOTARGET (2017)
Analysis of mebendazole binding to its target biomolecule by laser flash photolysis
Dolors Jornet et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2016)
Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
Tara Williamson et al.
ONCOTARGET (2016)
Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
Marianne S. Poruchynsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The anthelmintic drug mebendazole inhibits growth, migration and invasion in gastric cancer cell model
Laine Celestino Pinto et al.
TOXICOLOGY IN VITRO (2015)
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells
Zhi-Jie Hou et al.
ONCOTARGET (2015)
Polymer-drug conjugates: Origins, progress to date and future directions
Jindrich Kopecek
ADVANCED DRUG DELIVERY REVIEWS (2013)
HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity
Tomas Etrych et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
Ren-Yuan Bai et al.
NEURO-ONCOLOGY (2011)
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Hiroshi Maeda
BIOCONJUGATE CHEMISTRY (2010)
Development of HPMA copolymer-anticancer conjugates: Clinical experience and lessons learnt
Ruth Duncan
ADVANCED DRUG DELIVERY REVIEWS (2009)
In Vivo Expansion of Activated Naive CD8+ T Cells and NK Cells Driven by Complexes of IL-2 and Anti-IL-2 Monoclonal Antibody As Novel Approach of Cancer Immunotherapy
Jakub Tomala et al.
JOURNAL OF IMMUNOLOGY (2009)
Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells
Nicole Doudican et al.
MOLECULAR CANCER RESEARCH (2008)
Prodrugs for Amines
Ana L. Simplicio et al.
MOLECULES (2008)
Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery
Nobuhiro Nishiyama et al.
PHARMACOLOGY & THERAPEUTICS (2006)
HPMA copolymers with pH-controlled release of doxorubicin -: In vitro cytotoxicity and in vivo antitumor activity
K Ulbrich et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
